HemaSource was founded by dedicated healthcare executives with extensive and diverse backgrounds in medical products, healthcare software, distribution, global markets, logistics, product development, manufacturing and finance.

Tom Jordan

President & Chief Executive Officer

Mr. Jordan is the President and Chief Executive Officer of HemaSource. Prior to joining HemaSource, he spent 11 years with Terumo BCT and most recently held the title of Executive Vice President, Worldwide Commercial Operations. Mr. Jordan also spent 12 years at Baxter International. He has over 25 years of global healthcare experience leading companies in all regions of the world with emphasis in commercial, medical, business development, finance, logistics and product & software development. He has delivered superior business results in many different segments of the global healthcare market including pharmaceuticals, molecular diagnostics, medical devices, medical equipment and software. Mr. Jordan is a graduate of the University of Iowa (BA, Finance) and holds dual citizenship from Germany/United States.

Julie Babcock

Chief Financial Officer

Ms. Babcock joined HemaSource in 2020 and has twenty years of executive financial leadership. She brings extensive experience with mergers and acquisitions, strategic planning and analysis, operational and corporate accounting/finance in both publicly held and private equity backed businesses. Most recently, Ms. Babcock was the Vice President of Accounting for TIDI Products, LLC, an acquisitive medical device manufacturer focused on infection prevention and falls management. Her experience also includes over five years as Chief Financial Officer for AtriCure, Inc., a medical device manufacturer focused on the treatment of atrial fibrillation and ten years in various executive financial roles with School Specialty, a distribution business focused on serving the K-12 school market. Ms. Babcock began her career with Deloitte & Touche LLP. She is a Certified Public Accountant and has her Master’s in Business Administration.

Beata Puncevic

Chief Technology Officer

Ms. Puncevic is the Chief Technology Officer at HemaSource, bringing 20 years of extensive experience in software engineering and technology leadership within high-growth environments. Before joining HemaSource, Beata served as CTO at Techstars, the world's largest early-stage startup investor, where she led the creation of a proprietary tech powered investment platform. Prior to that, she led the B2B division of Healthgrades, launching new products serving hospital and pharmaceutical customers. Beata's career also includes transformative roles at Health Care Service Corporation and BCBS of Michigan, where she built and led high-performing teams, executed strategic technology initiatives, and improved operational efficiencies. Beata holds a Bachelor of Science in Finance from the University of Illinois. Her leadership at HemaSource is pivotal in driving technology innovation and software strategies that align with the company’s mission to optimize healthcare product distribution and enhance customer operations

Joe Malory

Senior Vice President Commercial Operations

Mr. Malory is the Senior Vice President For Commercial Operations at HemaSource. He leads all efforts as it relates to leveraging data to drive customer operational efficiencies along with the company internal processes. Mr. Malory also leads all of the company customer service operations and quality procedures. Prior to joining HemaSource, Mr. Malory spent over 17 years with COBE, Gambro and Terumo BCT where he proudly started working as an intern in college on the manufacturing floor and progressed his career as customer performance engineer, sales representative, software marketing and finally as an executive leading all marketing initiatives in Japan where he spent 4 years with his family. He holds a bachelor’s degree in Mechanical Engineering from Colorado School of Mines and his Masters of Business Administration from the University of Wyoming.

Mikhail Gurfinkel

Senior Vice President Product Strategy and General Counsel

Mr. Gurfinkel is SVP, Product Strategy and General Counsel at HemaSource. He brings with him 20 years of experience in private equity both on the operational and investment aspects of the business in a variety of industries.

He previously served as COO of Badlands NGLs LLC, a development stage petrochemical company focused on energy derivative projects, where he oversaw all aspects of investment and operations. Mikhail also served for 7 years as President and General Counsel, Americas Region, of Basic Element Company, a $20 billion Russian private industrial conglomerate focusing on energy, metals and mining, manufacturing and construction. In this capacity, he worked on execution and portfolio management of the firm's investments across the globe. He is responsible for the execution of strategic transactions valued at approximately $2 billion.

Prior to that tenure, Mr. Gurfinkel was a corporate attorney for over seven years at two of the world's leading law firms, Clifford Chance LLP and Hunton & Williams LLP, where he specialized in M&A, banking and securities law and represented a mix of Fortune 500 clients including industrials, financial institutions and real estate companies in a wide range of matters including corporate finance, real estate acquisition and development, venture capital investment, public and private investments and issuance of debt and equity. Mr. Gurfinkel has a B.A. in philosophy and a Juris Doctorate from Boalt Hall School of Law at the University of California, Berkeley.

Kent F. Janes

Senior Vice President Procurement & Operations

Mr. Janes joined HemaSource in November of 2010. He brings with him 21 years of experience in supply chain management, operations and manufacturing in many industries including automotive, electronics, printing. Mr. Janes began as a buyer of raw components in manufacturing environments and has steadily progressed to the point where he was most recently Director of Operations at Franklin Covey. At Franklin, Mr. Janes was responsible for all printing and packaging operations. Mr. Janes previous work experience in various companies and industries provides him with a broad perspective in areas of supply chain management and operations.

Michelle Autry

Director of Quality Assurance

Ms. Autry is the Director of Quality Assurance at HemaSource. She has been with the company for 2 years directly supporting the company’s largest distribution warehouse and playing a critical role in customer service. Prior to joining HemaSource, her 19-year career has been focused in non-acute medical product distribution including 15 years of focus in the plasma supply chain market. Ms. Autry started her career in 2001 with various versions of Medical Supplies of America. During her tenure, she managed many different departments including customer service, purchasing, operations, accounting and logistics ultimately proving a depth of knowledge in various department’s process and procedures. Ms. Autry was elevated to her current position as Director of Quality Assurance in November 2019. She holds a bachelor’s degree in Business Administration with a Minor in Marketing from Tusculum College.

Dr. Marcus Breu

General Manager HemaSource Deutschland GmbH

Mr. Breu joined HemaSource in February 2019 and is responsible for the development and expansion of the European business unit of HemaSource Deutschland GmbH. He has over 27 years of experience in the field of health care. Mr. Breu began his career as a health economist and health care consultant. He then worked successfully at Gambro and Baxter as Business Unit Director Renal for 17 years. His focus was on the further development of the strategic and operational business model, sales and marketing, merger and acquisition, market access activities and key customer management. Prior to joining HemaSource he was managing director for ITF Pharma GmbH responsible for business and strategy development and the market launch of heparin biosimilars. Mr. Breu holds a degree in business administration from the Ludwigs-Maximilians-University Munich and a doctorate in economic science (PhD) from the University of the Bundeswehr Munich.

Jonathan Harber

SVP of Business & Technology Systems

Jonathan Harber is the SVP of Business & Technology Systems at HemaSource. Before joining HemaSource he held positions as CTO and CISO at IntelliSpeX, CIO & CISO, Marine Corps Community Services, Managing Partner, Strategic Development Partners, Vice President, Shared Services, Healthcare Partners, CIO, Blood Systems, SVP, Global IT Infrastructure & Operations, EFD/eFunds, CIO & CISO, Corporate Systems, CTO & CISO, FundsXpress Financial Network, Director of IT Infrastructure & Operations at Health Net, and Vice President, Sales and Field Operations, WinStar Communications. He is an 11-year veteran of the United States Marine Corps, and holds a CISSP certification from ISC(2) and an Authorizing Official certification with the Department of Defense. He has Bachelor of Science from the United States Naval Academy in Engineering & Physical Science, and an MBA from West Texas A&M University with a concentration in Finance and Economics.